Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Center, Randomized, Double-Blind Controlled Study of Topical Endoluminal Pancreatic Duct Lidocaine for Prevention of Post-ERCP Pancreatitis

NCT00953199 is registered in ClinicalTrials.gov with Abraham Mathew MD as lead sponsor.

NCT NCT00953199
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00953199 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Center, Randomized, Double-Blind Controlled Study of Topical Endoluminal Pancreatic Duct Lidocaine for Prevention of Post-ERCP Pancreatitis
Lead sponsor
Abraham Mathew MD
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2010
Completion date
May 31, 2013
Enrollment
506 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatitis